200 related articles for article (PubMed ID: 34300306)
1. Restoration of Osteogenesis by CRISPR/Cas9 Genome Editing of the Mutated
Jung H; Rim YA; Park N; Nam Y; Ju JH
J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300306
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9 correction of a dominant cis-double-variant in COL1A1 isolated from a patient with osteogenesis imperfecta increases the osteogenic capacity of induced pluripotent stem cells.
Cao Y; Li L; Ren X; Mao B; Yang Y; Mi H; Guan Y; Li S; Zhou S; Guan X; Yang T; Zhao X
J Bone Miner Res; 2023 May; 38(5):719-732. PubMed ID: 36734182
[TBL] [Abstract][Full Text] [Related]
3. Identification of a family with van der Hoeve's syndrome harboring a novel COL1A1 mutation and generation of patient-derived iPSC lines and CRISPR/Cas9-corrected isogenic iPSCs.
Li S; Mei L; He C; Cai X; Wu H; Wu X; Liu Y; Feng Y; Song J
Hum Cell; 2024 May; 37(3):817-831. PubMed ID: 38379122
[TBL] [Abstract][Full Text] [Related]
4. Amelioration of osteogenesis in iPSC-derived mesenchymal stem cells from osteogenesis imperfecta patients by endoplasmic reticulum stress inhibitor.
Duangchan T; Tawonsawatruk T; Angsanuntsukh C; Trachoo O; Hongeng S; Kitiyanant N; Supokawej A
Life Sci; 2021 Aug; 278():119628. PubMed ID: 34015290
[TBL] [Abstract][Full Text] [Related]
5. AAV-based gene editing of type 1 collagen mutation to treat osteogenesis imperfecta.
Yang YS; Sato T; Chaugule S; Ma H; Xie J; Gao G; Shim JH
Mol Ther Nucleic Acids; 2024 Mar; 35(1):102111. PubMed ID: 38261950
[TBL] [Abstract][Full Text] [Related]
6. Osteoblastic differentiation of bone marrow mesenchymal stromal cells in Bruck Syndrome.
Kaneto CM; Lima PS; Zanette DL; Oliveira TY; de Assis Pereira F; Lorenzi JC; Dos Santos JL; Prata KL; Neto JM; de Paula FJ; Silva WA
BMC Med Genet; 2016 May; 17(1):38. PubMed ID: 27146342
[TBL] [Abstract][Full Text] [Related]
7. Modification of COL1A1 in Autologous Adipose Tissue-Derived Progenitor Cells Rescues the Bone Phenotype in a Mouse Model of Osteogenesis Imperfecta.
Liu Y; Wang Z; Ju M; Zhao Y; Jing Y; Li J; Shao C; Fu T; Lv Z; Li G
J Bone Miner Res; 2021 Aug; 36(8):1521-1534. PubMed ID: 33950576
[TBL] [Abstract][Full Text] [Related]
8. Mutation analysis of the COL1A1 and COL1A2 genes in Vietnamese patients with osteogenesis imperfecta.
Ho Duy B; Zhytnik L; Maasalu K; Kändla I; Prans E; Reimann E; Märtson A; Kõks S
Hum Genomics; 2016 Aug; 10(1):27. PubMed ID: 27519266
[TBL] [Abstract][Full Text] [Related]
9. Mutations in the COL1A1 and COL1A2 genes associated with osteogenesis imperfecta (OI) types I or III.
Augusciak-Duma A; Witecka J; Sieron AL; Janeczko M; Pietrzyk JJ; Ochman K; Galicka A; Borszewska-Kornacka MK; Pilch J; Jakubowska-Pietkiewicz E
Acta Biochim Pol; 2018; 65(1):79-86. PubMed ID: 29543922
[TBL] [Abstract][Full Text] [Related]
10. Lack of correlation between the type of COL1A1 or COL1A2 mutation and hearing loss in osteogenesis imperfecta patients.
Hartikka H; Kuurila K; Körkkö J; Kaitila I; Grénman R; Pynnönen S; Hyland JC; Ala-Kokko L
Hum Mutat; 2004 Aug; 24(2):147-54. PubMed ID: 15241796
[TBL] [Abstract][Full Text] [Related]
11. Generation of a non-integrated induced pluripotent stem cell line from urine cells of a Chinese osteogenesis imperfecta type I patient.
Luan J; Cui Y; Wang J; Liang Y; Zhao Y; Zhang G; Han J
Stem Cell Res; 2022 Jul; 62():102827. PubMed ID: 35660813
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive genetic analyses using targeted next-generation sequencing and genotype-phenotype correlations in 53 Japanese patients with osteogenesis imperfecta.
Ohata Y; Takeyari S; Nakano Y; Kitaoka T; Nakayama H; Bizaoui V; Yamamoto K; Miyata K; Yamamoto K; Fujiwara M; Kubota T; Michigami T; Yamamoto K; Yamamoto T; Namba N; Ebina K; Yoshikawa H; Ozono K
Osteoporos Int; 2019 Nov; 30(11):2333-2342. PubMed ID: 31363794
[TBL] [Abstract][Full Text] [Related]
13. Clinical characteristics and the identification of novel mutations of COL1A1 and COL1A2 in 61 Chinese patients with osteogenesis imperfecta.
Zhang H; Yue H; Wang C; Hu W; Gu J; He J; Fu W; Hu Y; Li M; Zhang Z
Mol Med Rep; 2016 Nov; 14(5):4918-4926. PubMed ID: 27748872
[TBL] [Abstract][Full Text] [Related]
14. A novel RNA-splicing mutation in COL1A1 gene causing osteogenesis imperfecta type I in a Chinese family.
Xia XY; Cui YX; Huang YF; Pan LJ; Yang B; Wang HY; Li XJ; Shi YC; Lu HY; Zhou YC
Clin Chim Acta; 2008 Dec; 398(1-2):148-51. PubMed ID: 18755172
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel COL1A1 frameshift mutation, c.700delG, in a Chinese osteogenesis imperfecta family.
Wang X; Pei Y; Dou J; Lu J; Li J; Lv Z
Genet Mol Biol; 2015 Mar; 38(1):1-7. PubMed ID: 25983617
[TBL] [Abstract][Full Text] [Related]
16. The synergistic effect of NELL1 and adipose-derived stem cells on promoting bone formation in osteogenesis imperfecta treatment.
Liu Y; Ju M; Wang Z; Li J; Shao C; Fu T; Jing Y; Zhao Y; Lv Z; Li G
Biomed Pharmacother; 2020 Aug; 128():110235. PubMed ID: 32454289
[TBL] [Abstract][Full Text] [Related]
17. A novel transgenic murine model with persistently brittle bones simulating osteogenesis imperfecta type I.
Liu Y; Wang J; Liu S; Kuang M; Jing Y; Zhao Y; Wang Z; Li G
Bone; 2019 Oct; 127():646-655. PubMed ID: 31369917
[TBL] [Abstract][Full Text] [Related]
18. Mutational analysis of COL1A1 and COL1A2 genes among Estonian osteogenesis imperfecta patients.
Zhytnik L; Maasalu K; Reimann E; Prans E; Kõks S; Märtson A
Hum Genomics; 2017 Aug; 11(1):19. PubMed ID: 28810924
[TBL] [Abstract][Full Text] [Related]
19. DNA methyltransferases inhibitor azacitidine improves the skeletal phenotype of mild osteogenesis imperfecta by reversing the impaired osteogenesis and excessive osteoclastogenesis.
Shao C; Liu Y; Zhao Y; Jing Y; Li J; Lv Z; Fu T; Wang Z; Li G
Bone; 2023 May; 170():116706. PubMed ID: 36822490
[TBL] [Abstract][Full Text] [Related]
20. Skeletal phenotypes in adult patients with osteogenesis imperfecta-correlations with COL1A1/COL1A2 genotype and collagen structure.
Hald JD; Folkestad L; Harsløf T; Lund AM; Duno M; Jensen JB; Neghabat S; Brixen K; Langdahl B
Osteoporos Int; 2016 Nov; 27(11):3331-3341. PubMed ID: 27256333
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
